NIHSS App

NIHSS

NIHSS

Doctot NIHSS is a intuitive, user friendly tool for clinicians to efficiently evaluate Stroke patients with the NIHSS scale.

Boehringer

Doctot NIHSS is kindly supported by an unrestricted educational grant
from Boehringer.

Boehringer

More About Doctot NIHSS

This interactive scale assists in the diagnosis by:

  • providing the 14 components of the NIHSS in an easy-to-use wizard
  • automatically calculating the patient’s NIHSS score
  • categorising the patient’s NIHSS score
  • including images used to display to the patient to determine their descriptive abilities
  • providing users with the ability to take notes for untestable criteria
  • providing ‘Stopwatch’ functionality where timing of patients actions/responses is required. (The most suitable options are selected based on the time taken)

An “Information” section is included to provide the user with background details. A “Help” section is included to aid in the use of the tool.

Functionality is also included for:

  • PIN Protection for security purposes
  • Patient Results Management (save, delete & sort options)
  • Automatic Email Generation of each patient assessment result
  • Shake-to-Reset Scale functionality

What’s New In Version 1.0

Updates for IOS 4.0 and later.

App Screenshots

nihss1nihss2nihss3nihss4nihss5

App Development

Developed under the Doctot brand, Doctot NIHSS combines the medical and technical expertise of Clinisynergy Ltd. with the creative and design strengths of Tricycle Interactive Ltd.

Doctot NIHSS is kindly supported by an unrestricted educational grant from Boehringer.

Looking for an App?

An extensive suite of software applications are being planned for development. If you would like to have a specific application developed for your discipline or area of expertise, please contact us.

About Doctot

Doctot combines the Medical and Technical expertise of Clinisynergy Ltd with the Creative and Design strengths of Tricycle Interactive Ltd.

Read More >

Connect

Connect with Doctot - follow us on Twitter or like our facebook page